Publications by authors named "Andrew Messenger"

Claim this Profile
F
Findings from the Assessment of real-world Disease characteristics and outcomes in Alopecia Areata in a Global non-Interventional Observational cohort (ADAAGIO) study.
Keith L Davis, Andrew Messenger, Sergio Vañó-Galván, Helen Tran, Lynne Napatalung

Clin Exp Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British Association of Dermatologists living guideline for managing people with alopecia areata 2025.
Matthew J Harries, Alia Ahmed, Anna Ascott, Kashif Bhatti, Joseph Earley, Andrew G Messenger

Br J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024.
Nekma Meah, Jane Li, Dmitri Wall, Katherine York, Bevin Bhoyrul, Andrew Messenger

J Eur Acad Dermatol Venereol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata.
Kent A Hanson, Sergio Vañó-Galván, Andrew Messenger, Helen Tran, Lynne Napatalung

Dermatol Ther (Heidelb)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontal Fibrosing Alopecia: An Update.
Andrew G Messenger, Leila Asfour, Matthew Harries

Am J Clin Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British Association of Dermatologists living guideline for managing people with alopecia areata 2024.
Matthew J Harries, Anna Ascott, Leila Asfour, Paul Farrant, Gordon Hale, Andrew G Messenger

Br J Dermatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifetime incidence and healthcare disparities in alopecia areata: a UK population-based cohort study.
Andrew R Thompson, Christos Tziotzios, John Nesnas, Rowena Randall, Maciej Czachorowski, Andrew G Messenger

Br J Dermatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to 'The journey of patients with skin diseases from the first consultation to the diagnosis in a representative sample of the European general population from the EADV burden of skin diseases study'.
Niels Bootsma, Fabio Zucchelli, Leila Asfour, Andrew G Messenger

J Eur Acad Dermatol Venereol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity.

JAMA Dermatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing the financial burden of alopecia areata and its predictors.
Fabio Zucchelli, Matthew Harries, Andrew Messenger, Kerry Montgomery

Skin Health Dis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review.
Adam Daunton, Matthew Harries, Rodney Sinclair, Ralf Paus, Antonella Tosti, Andrew Messenger

Am J Clin Dermatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Male pattern hair loss: Can developmental origins explain the pattern?
Leah C Redmond, Summik Limbu, Bessam Farjo, Andrew G Messenger, Claire A Higgins

Exp Dermatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study.
Susan Holmes, Matthew Harries, Abby E Macbeth, Wing S Chiu, Simon de Lusignan, Andrew G Messenger

Clin Exp Dermatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alopecia areata and risk of common infections: a population-based cohort study.
Andrew G Messenger, Matthew Harries, Abby E Macbeth, Wing Sin Chiu, Susan Holmes

Clin Exp Dermatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care.
Abby E Macbeth, Susan Holmes, Matthew Harries, Wing Sin Chiu, Christos Tziotzios, Andrew G Messenger

Br J Dermatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib in Alopecia Areata.
Andrew Messenger, Matthew Harries

N Engl J Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, management and the associated burden of mental health illness, atopic and autoimmune conditions, and common infections in alopecia areata: protocol for an observational study series.
Matthew Harries, Abby E Macbeth, Susan Holmes, Andrew R Thompson, Wing Sin Chiu, Andrew G Messenger

BMJ Open· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Alopecia Areata Consensus of Experts (ACE) study part II: Results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata.
Nekma Meah, Dmitri Wall, Katherine York, Bevin Bhoyrul, Laita Bokhari, Andrew Messenger

J Am Acad Dermatol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shedding light on therapeutics in alopecia and their relevance to COVID-19.
Nicole Fagan, Nekma Meah, Katherine York, Laita Bokhari, Godfrey Fletcher, Andrew Messenger

Clin Dermatol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS).
Dmitri Wall, Nekma Meah, Katherine York, Bevin Bhoyrul, Laita Bokhari, Andrew Messenger

JAMA Dermatol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata.
Nekma Meah, Dmitri Wall, Katherine York, Bevin Bhoyrul, Laita Bokhari, Andrew Messenger

J Am Acad Dermatol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autosomal-dominant hypotrichosis with woolly hair: Novel gene locus on chromosome 4q35.1-q35.2.
Annika E Schlaweck, Rachid Tazi-Ahnini, F Buket Ü Basmanav, Javed Mohungoo, Sandra M Pasternack-Ziach, Andrew Messenger

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the disease.
Fatma N Hamed, Annika Åstrand, Marta Bertolini, Alfredo Rossi, Afsaneh Maleki-Dizaji, Andrew G Messenger

PLoS One· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the disease.
Fatma N Hamed, Annika Åstrand, Marta Bertolini, Alfredo Rossi, Afsaneh Maleki-Dizaji, Andrew G Messenger

PLoS One· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.
Christos Tziotzios, Christos Petridis, Nick Dand, Chrysanthi Ainali, Jake R Saklatvala, Andrew Messenger

Nat Commun· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis